Date of Award
5-2016
Document Type
Open Access Honors Thesis
Degree Name
Bachelor of Science (BS)
Department
Management
Advisor
Zaur Rzakhanov
Director
Rajini Srikanth
Subject Categories
Business | Corporate Finance | Technology and Innovation
Abstract
Biotechnology investment, in the second quarter of 2015, hauled in a record $2.3 billion worth of venture capital. The 126 deals struck marked the biggest quarterly investment (up 32% from the prior quarter) since reporting started in 1995. With $3.8 billion invested in these pre-IPO ventures by mid-2015, the biotech industry soared past the $6 billion of venture capital cash invested in 2014. These numbers illustrate how early-stage research, with unproven science, has been revived after a decade of VCs shying away. Out of the $2.3 billion raised in Q2, $1.5 billion went to early-stage companies while $733 million went to startups receiving money for the first time.
Recommended Citation
Sumadi, Faris, "Event-Based Biotechnology Stock Price Movement: Valuing Success and Failure in Biotechnology Product Development" (2016). Honors College Theses. 23.
https://scholarworks.umb.edu/honors_theses/23